Remember when you used to spend untold hours sitting around a table over a beer or coffee with your friends, solving all the problems of the world, debating all the "big questions" of the day?  That's what a Café Scientifique is all about.  Simply put, it is larger and slightly more organized version of those conversations. It's an opportunity to bring together researchers with members of the public to spark a discussion about some of the most interesting- and sometimes contentious-research currently underway in Canada.

CIHR & University of Manitoba present
CAFE SCIENTIFIQUE- 2012/2013
at McNally Robinson Booksellers
1120 Grant Avenue – Event Atrium 7:00 pm

Click in the right column to RSVP

NATURE AND NURTURE (NOT VERSUS): THE NEW SCIENCE OF EPIGENETICS
January 28, 2013
Experts: Dr. Jim Davie, Dr. Kirk McManus, Dr. Mojgan Rastegar
Moderator: Dr. Peter Cattini

Epigenetics steps in where mapping the human genome left off.  Nature says we inherit our genetic make-up or DNA code from our parents. Many believe this code and the genes it represents set the ‘program’ for who we are and what health risks we might possess. Nurture (or epigenetics) says that this program can be ‘hacked’ by life experience, either increasing or decreasing health risks already in our DNA code. Join our experts in a discussion about whether we can control our health destinies by controlling what we eat, drink, breathe, and where we live.


DRUG DISCOVERY: THE 21ST CENTURY PETRI DISH
February 25, 2013
Experts: Dr. Donald Miller, Dr. Frank Schweizer, Dr. John Sorensen, Dr. George Zhanel
Moderator:  Dr. Albert Friesen, President, Medicure; Co-Chair, Manitoba Innovation Council

The many life-saving drugs that appear on our drug store shelves and that are prescribed by physicians every day to treat diseases and infections all had their start in a research laboratory. In the 21st century, the demand for new antibiotics and anticancer drugs is an urgent focus, given antibiotic resistance and the need to tailor our fight against diseases. Come joint our experts as they share the challenges and rewards of their current drug discovery research and the implications for health care these drugs hold.